retatrutide phase 2 results obesity nejm 2023 Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people TRIUMPH-1 Trial Results: Retatrutide for

The recommended intake is 1.2 to 1.6 grams of protein per kilogram of body weight daily

Retatrutide is still in clinical trials, so while there arent official rules yet, the study criteria can give a general idea of who it may be intended for

By promoting the release of GLP-1 a key hormone involved in satiety resM GLP-1 postbiotic helps a user to feel more satisfied after meals and manage cravings. Is the gut the key to weight management

Maandelijkse injecties als informeel onderhoud passen daar niet in

Despite numerous studies, the causes of the obesity epidemic are still not fully understood, and traditional calorie-restricted diets still lack long-term effects (133)

Lastly, for those who are eligible, metabolic/bariatric surgery should remain part of the conversation, as it is one of the most effective and durable obesity treatments we have